Retatrutide, from Soma Pharmaceuticals , represents a promising development in weight control . This unique drug combines hormonal signaling properties with gut-derived pathway engagement, showing impressive potential in patient data for body loss . Experts believe Retatrutide may represent a new option for people facing obesity conditions . Soma C